| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunocytochemistry; human; loading ...; fig s3a
- western blot; human; loading ...; fig 2e
| Greenberg R, Long H, Swigut T, Wysocka J. Single Amino Acid Change Underlies Distinct Roles of H2A.Z Subtypes in Human Syndrome. Cell. 2019;178:1421-1436.e24 pubmed publisher |
- immunohistochemistry; human; 1:100; loading ...; fig 2s1e
| Achberger K, Probst C, Haderspeck J, Bolz S, Rogal J, Chuchuy J, et al. Merging organoid and organ-on-a-chip technology to generate complex multi-layer tissue models in a human retina-on-a-chip platform. elife. 2019;8: pubmed publisher |
- immunocytochemistry; human; loading ...; fig 3f
| Laugsch M, Bartusel M, Rehimi R, Alirzayeva H, Karaolidou A, Crispatzu G, et al. Modeling the Pathological Long-Range Regulatory Effects of Human Structural Variation with Patient-Specific hiPSCs. Cell Stem Cell. 2019;24:736-752.e12 pubmed publisher |
- immunocytochemistry; human
| Kim K, Ossipova O, Sokol S. Neural crest specification by inhibition of the ROCK/Myosin II pathway. Stem Cells. 2015;33:674-85 pubmed publisher |
| Hsu F, Wu Q, Fabyanic E, Wei A, Wu H, Clark A. TET1 facilitates specification of early human lineages including germ cells. iScience. 2023;26:107191 pubmed publisher |
| Collier A, Piekos S, Liu A, Pattison J, Felix F, Bailetti A, et al. GRHL2 and AP2a coordinate early surface ectoderm lineage commitment during development. iScience. 2023;26:106125 pubmed publisher |
| Yaacov R, Eshel R, Farhi E, Shemuluvich F, Kaplan T, Birnbaum R. Functional characterization of the ZEB2 regulatory landscape. Hum Mol Genet. 2018;: pubmed publisher |
| Guye P, Ebrahimkhani M, Kipniss N, Velazquez J, Schoenfeld E, Kiani S, et al. Genetically engineering self-organization of human pluripotent stem cells into a liver bud-like tissue using Gata6. Nat Commun. 2016;7:10243 pubmed publisher |
| Li X, Chen C, Wang F, Huang W, Liang Z, Xiao Y, et al. KCTD1 suppresses canonical Wnt signaling pathway by enhancing ?-catenin degradation. PLoS ONE. 2014;9:e94343 pubmed publisher |
| Zhang Z, Liu Y, Li S, Guo L, Zhao Y, Qian S, et al. Suv39h1 mediates AP-2?-dependent inhibition of C/EBP? expression during adipogenesis. Mol Cell Biol. 2014;34:2330-8 pubmed publisher |
| Ding X, Yang Z, Zhou F, Wang F, Li X, Chen C, et al. Transcription factor AP-2? regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression. Int J Biochem Cell Biol. 2013;45:1647-56 pubmed publisher |
| Zou L, Sun Y, Wang M, Zhan Q. Aurora-A interacts with AP-2? and down regulates its transcription activity. PLoS ONE. 2011;6:e23110 pubmed publisher |
| Li Q, Luo C, LOHR C, Dashwood R. Activator protein-2? functions as a master regulator of multiple transcription factors in the mouse liver. Hepatol Res. 2011;41:776-83 pubmed publisher |
| Su B, Tang H, Deng M, Liao Q, Zeng X, Zhang W, et al. Stage-associated dynamic activity profile of transcription factors in nasopharyngeal carcinoma progression based on protein/DNA array analysis. OMICS. 2011;15:49-60 pubmed publisher |
| Zhang X, Leung Y, Ho S. AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells. Oncogene. 2007;26:7346-54 pubmed |
